Expert Opinion on Emerging Drugs, Volume 25, Issue 3 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Emerging Drugs, Volume 25, Issue 3 (2020)

See all volumes and issues
Vol 29, 2024 Vol 28, 2023 Vol 27, 2022 Vol 26, 2021 Volume 25, 2020 Vol 24, 2019 Vol 23, 2018 Vol 22, 2017 Vol 21, 2016 Vol 20, 2015 Vol 19, 2014 Vol 18, 2013 Vol 17, 2012 Vol 16, 2011 Vol 15, 2010 Vol 14, 2009 Vol 13, 2008 Vol 12, 2007 Vol 11, 2006 Vol 10, 2005 Vol 9, 2004 Vol 8, 2003 Vol 7, 2002 Vol 6, 2001 Vol 6, 2001 Vol 5, 2000 Vol 4, 1999 Vol 3, 1998 Vol 2, 1997
Download citations Download PDFs Download issue

Review

Emerging drugs for the treatment of hidradenitis suppurativa
Alecia S Folkes, Faris Z Hawatmeh, Alan Wong & Francisco A Kerdel
Pages: 201-211
Published online: 22 Jul 2020
AbstractforEmerging drugs for the treatment of hidradenitis suppurativa | Full Text | References | PDF (303.1 KB) | EPUB
  • 456 Views
  • 8 CrossRef citations
  • 0Altmetric
Clinical trials and novel therapeutics in dermatomyositis
Tanya Chandra & Rohit Aggarwal
Pages: 213-228
Published online: 10 Jul 2020
AbstractforClinical trials and novel therapeutics in dermatomyositis | Full Text | References | PDF (702.7 KB) | EPUB
  • 827 Views
  • 9 CrossRef citations
  • 0Altmetric
Emerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
Toshio Fujino, Kenichi Suda & Tetsuya Mitsudomi
Pages: 229-249
Published online: 16 Jul 2020
AbstractforEmerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer | Full Text | References | PDF (7.4 MB) | EPUB | Supplemental
  • 1410 Views
  • 21 CrossRef citations
  • 0Altmetric
Emerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists
Raj A. Shah, Naim Alkhouri & Kris V Kowdley
Pages: 251-260
Published online: 12 Aug 2020
AbstractforEmerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists | Full Text | References | PDF (768.6 KB) | EPUB
  • 407 Views
  • 10 CrossRef citations
  • 0Altmetric
Emerging drugs for the treatment of diabetic retinopathy
Elio Striglia, Andrea Caccioppo, Niccolò Castellino, Michele Reibaldi & Massimo Porta
Pages: 261-271
Published online: 05 Aug 2020
AbstractforEmerging drugs for the treatment of diabetic retinopathy | Full Text | References | PDF (317.6 KB) | EPUB
  • 670 Views
  • 14 CrossRef citations
  • 0Altmetric
Emerging drugs for the treatment of chronic pruritic diseases
Kayla Fourzali, Rachel Shireen Golpanian & Gil Yosipovitch
Pages: 273-284
Published online: 12 Aug 2020
AbstractforEmerging drugs for the treatment of chronic pruritic diseases | Full Text | References | PDF (962 KB) | EPUB
  • 308 Views
  • 7 CrossRef citations
  • 0Altmetric
Emerging drugs for the treatment of neuromyelitis optica
Ankelien Duchow, Claudia Chien, Friedemann Paul & Judith Bellmann-Strobl
Pages: 285-297
Published online: 25 Aug 2020
AbstractforEmerging drugs for the treatment of neuromyelitis optica | Full Text | References | PDF (591.1 KB) | EPUB
  • 553 Views
  • 14 CrossRef citations
  • 0Altmetric
Emerging drugs for the treatment of light chain amyloidosis
Rajshekhar Chakraborty & Suzanne Lentzsch
Pages: 299-317
Published online: 24 Aug 2020
AbstractforEmerging drugs for the treatment of light chain amyloidosis | Full Text | References | PDF (708.6 KB) | EPUB
  • 847 Views
  • 8 CrossRef citations
  • 0Altmetric
Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs
Madia Lozupone, Vincenzo Solfrizzi, Francesca D’Urso, Ilaria Di Gioia, Rodolfo Sardone, Vittorio Dibello, Roberta Stallone, Angelo Liguori, Chiara Ciritella, Antonio Daniele, Antonello Bellomo, Davide Seripa & Francesco Panza
Pages: 319-335
Published online: 20 Aug 2020
AbstractforAnti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs | Full Text | References | PDF (487.8 KB) | EPUB
  • 1583 Views
  • 48 CrossRef citations
  • 0Altmetric
Emerging therapeutics for the management of COVID 19
Sujit Kumar Debnath, Rohit Srivastava & Abdelwahab Omri
Pages: 337-351
Published online: 08 Sep 2020
AbstractforEmerging therapeutics for the management of COVID 19 | Full Text | References | PDF (1.4 MB) | EPUB
  • 1263 Views
  • 6 CrossRef citations
  • 0Altmetric

Mini-Review

Emerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors
Haritha G. Reddy, Angel Qin & Gregory P. Kalemkerian
Pages: 353-366
Published online: 04 Aug 2020
AbstractforEmerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors | Full Text | References | PDF (2.7 MB) | EPUB
  • 413 Views
  • 4 CrossRef citations
  • 0Altmetric
Emerging drugs for treatment of focal segmental glomerulosclerosis
Howard Trachtman
Pages: 367-375
Published online: 12 Aug 2020
AbstractforEmerging drugs for treatment of focal segmental glomerulosclerosis | Full Text | References | PDF (290.7 KB) | EPUB
  • 358 Views
  • 9 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Current and emerging drug treatment strategies to tackle sickle cell anemia
Yogindra Persaud et al.
Review Article | Published online: 22 Jul 2024
Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials
Willemien F.J. Hof et al.
Review Article | Published online: 4 Jul 2024
Open Access
Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update
Joshua Winograd et al.
Review Article | Published online: 14 Jun 2024
Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer’s disease
Hui Jue Wang et al.
Review Article | Published online: 11 Jun 2024
View all latest articles